StockNews.com began coverage on shares of vTv Therapeutics (NASDAQ:VTVT – Free Report) in a report released on Saturday. The firm issued a hold rating on the biotechnology company’s stock. vTv Therapeutics Stock Performance Shares of vTv Therapeutics stock opened at $0.35 on Friday. vTv Therapeutics has a one year low of $0.35 and a one […]
Topline data results from the pivotal STRIDE study are expected in December 2023IRVINE, Calif., Nov. 13, 2023 Reneo Pharmaceuticals, Inc. , a clinical-stage pharmaceutical company focused on the.
Reneo Pharmaceuticals Reports Third Quarter 2023 Financial Results eagletribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eagletribune.com Daily Mail and Mail on Sunday newspapers.
StockNews.com initiated coverage on shares of vTv Therapeutics (NASDAQ:VTVT – Free Report) in a report released on Saturday morning. The brokerage issued a hold rating on the biotechnology company’s stock. vTv Therapeutics Price Performance NASDAQ VTVT opened at $0.47 on Friday. The company has a market cap of $48.94 million, a PE ratio of -1.95 […]